GENERIC NAME: alfuzosin
BRAND NAME: Uroxatral
DRUG CLASS AND MECHANISM: Alfuzosin belongs to a class of drugs called alpha-blockers. It is used for increasing the flow of urine that is reduced by benign prostatic hypertrophy (BPH). Alpha blockers relax the muscles in the prostate gland and the neck of the bladder. This allows the urethra (the tube that conducts urine out of the bladder) to open wider so that urine flows more easily. Other medicines in this of drugs include terazosin (Hytrin), prazosin (Minipress), doxazosin (Cardura), and tamsulosin (Flomax). Alfuzosin was approved in June 2003.
PRESCRIBED FOR: Alfuzosin is used in adult men to treat slow urination due to benign prostatic hyperplasia. Most men experience an improvement in urination in 2 to 3 weeks.
SIDE EFFECTS: The most common side effects of alfuzosin are:
This side effects occur in fewer than 1 per every 15 patients.
As with other alpha blockers, postural hypotension (decreasing blood pressure upon standing, with or without dizziness) may develop within a few hours following ingestion of alfuzosin and can cause fainting.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.